LabCorp Enters Into License Agreement with Sequella

News   Oct 24, 2012

 
LabCorp Enters Into License Agreement with Sequella
 
 
 

RELATED ARTICLES

Two Studies Provide Significant Hope in the Fight Against Antibiotic Resistance

News

Two recent studies led by the University of Bristol provide significant new hope in the fight against antibiotic resistance.

READ MORE

Finding Drug Targets for Obesity, Diabetes

News

Technological breakthrough will likely be of great interest to biotechnology companies aspiring to build their drug pipeline in the metabolic disease area.

READ MORE

Screening for Disease or Toxins in a Drop of Blood

News

Scientist have developed a multinozzle emitter array (MEA), a silicon chip that can dramatically shorten the time it takes to identify proteins, peptides, and other molecular components within small volumes of biological samples.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE